Anti-PRAME Reference Antibody (Eureka patent anti-PRAME)
- Product Code: 140427
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used in cancer immunotherapy research, particularly in targeting PRAME (Preferentially Expressed Antigen in Melanoma), a protein overexpressed in various tumors including melanoma, lung, breast, and hematologic cancers. This reference antibody serves as a critical tool for validating PRAME expression in tumor tissues, enabling the development of targeted therapies such as CAR-T cells, bispecific antibodies, and other immuno-oncology agents. It supports assay development for patient stratification by identifying those most likely to respond to PRAME-directed treatments. Due to its high specificity and well-characterized binding properties, it is used as a benchmark in diagnostic test development and therapeutic antibody optimization. Its role in preclinical studies helps establish safety and efficacy profiles for emerging cancer therapies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-PRAME Reference Antibody (Eureka patent anti-PRAME)
Used in cancer immunotherapy research, particularly in targeting PRAME (Preferentially Expressed Antigen in Melanoma), a protein overexpressed in various tumors including melanoma, lung, breast, and hematologic cancers. This reference antibody serves as a critical tool for validating PRAME expression in tumor tissues, enabling the development of targeted therapies such as CAR-T cells, bispecific antibodies, and other immuno-oncology agents. It supports assay development for patient stratification by identifying those most likely to respond to PRAME-directed treatments. Due to its high specificity and well-characterized binding properties, it is used as a benchmark in diagnostic test development and therapeutic antibody optimization. Its role in preclinical studies helps establish safety and efficacy profiles for emerging cancer therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :